Moderna Stock Went Up By Over 5% As Session Comes To An End Today

Shares of Moderna jumped 5.97% to $161.62 at 15:24 EST on Monday, following yesterday's downward trend. The Nasdaq Stock Market is jumping 0.3% to $12,502.20, after two consecutive sessions in a row of gains, on what up to now seems, a somewhat positive trend exchanging session today. Moderna's last close was $152.52, 10.44% under its 52-week high of $178.50.

News about Moderna today

Early bet on Moderna sees top european fund gain 65% this year. According to today's article on Bloomberg Quint, "A Baillie Gifford & Co. health care fund run by an all-female team has surged past peers to a 65% gain this year, largely thanks to a far-sighted bet on medical stock Moderna Inc." Moderna shares rally as Canada doubles vaccine order. According to today's article on MarketWatch, "Shares of Moderna Inc. rallied 1.3% in morning trading Monday, after the biotechnology company said the Canadian government has doubled its order commitment for has gained 7.8%."

Moderna's Sales

Moderna's sales growth is 1428.1% for the present quarter and 13065.3% for the next. The company's growth estimates for the present quarter is a negative 48.6% and positive 565.7% for the next.

Moderna's Revenue

Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.

Moderna's Stock Top and Bottom Yearly Value

Moderna's stock is valued at $161.62 at 15:24 EST, under its 52-week high of $178.50 and way above its 52-week low of $17.68.

Moderna's Moving Average

Moderna's worth is way higher than its 50-day moving average of $91.57 and way higher than its 200-day moving average of $73.81.

Previous days news about Moderna

Moderna expects to provide up to 125 mln covid-19 vaccine doses globally in Q1. According to Business Insider on Fri Dec 4, "Moderna Inc. (MRNA) said Thursday that it expects to have between 100 million and 125 million doses of its potential COVID-19 vaccine available globally in the first quarter of 2021, with 85 million-100 million of those available in the U.S. And 15 million-25 million of those available outside of the U.S." Moderna to provide Israel health ministry with additional 4 million doses of its covid-19 vaccine candidate. According to MarketWatch on Fri Dec 4, "Moderna Inc. said Friday it is amending its supply agreement with the Israeli health ministry and will provide an additional 4 million doses of its experimental COVID-19 vaccine mRNA-1273."